Banca Transilvania S.A. (TLV)
Bucharest Stock Exchange · Romania · prices in RON · close of 22 Oct 2026
Key indicators
| Last close | RON 36.40 |
|---|---|
| 52-week range | 27.86 – 41.96 |
| Return, 1 month / 3 months | +3.9% / −2.4% |
| Return, 1 year / 3 years | +58.3% / +207.7% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 21.4% |
| Worst drawdown (1 year) | -12.1% |
| Average daily value traded | 19.84M RON |
| Dividend yield | 5.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Banca Transilvania is a Romanian bank based in Cluj-Napoca. It serves individual customers with everyday banking such as current accounts, savings products, consumer loans and mortgages, and it works with small and medium-sized businesses and larger corporate clients on lending, payments and other financial services. The bank also offers cards, online banking and insurance-related products through its branch network and digital channels across Romania.
On this site Banca Transilvania S.A. appears as a stock on the Bucharest Stock Exchange (Romania), code TLV, with prices in Romanian lei (RON). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Banca Transilvania S.A. (TLV) trades on the Bucharest Stock Exchange in Romania. It last closed at RON 36.40 on 22 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 4 of 122 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 58.3% and over the last three months it fell 2.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bucharest Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 10.9% | ||
| From 52-week high | -13.3% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.4% | ||
| 6-month return | 16.4% | ||
| 12-month return, skipping the last month | 52.3% | ||
| Stability (higher is calmer) | 93 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.1% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 19.84M RON | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.5% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +2.7% |
|---|---|
| 1 month | +3.9% |
| 3 months | −2.4% |
| 6 months | +16.4% |
| 1 year | +58.3% |
| 3 years | +207.7% |
| 5 years | +260.8% |
Signals
| 50-day / 200-day average | 35.59 / 32.82 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Jun 2026 | RON 1.2840 |
| 24 Nov 2025 | RON 0.7346 |
| 13 Jun 2025 | RON 1.7333 |
| 11 Jun 2024 | RON 1.2521 |
| 20 Oct 2023 | RON 1.1300 |
| 3 Jun 2022 | RON 0.1268 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bucharest Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.